Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Sell
42
-30
-42% -$7.56K ﹤0.01% 449
2026
Q1
$17.5K Sell
72
-3
-4% -$812 ﹤0.01% 349
2025
Q4
$22.2K Sell
75
-603
-89% -$181K ﹤0.01% 247
2025
Q3
$191K Sell
678
-25
-4% -$6.54K 0.03% 183
2025
Q2
$207K Sell
703
-518
-42% -$133K 0.04% 170
2025
Q1
$304K Sell
1,221
-725
-37% -$177K 0.06% 132
2024
Q4
$428K Buy
1,946
+518
+36% +$115K 0.09% 106
2024
Q3
$316K Hold
1,428
0.07% 125
2024
Q2
$247K Buy
1,428
+512
+56% +$89K 0.06% 133
2024
Q1
$175K Sell
916
-127
-12% -$23.2K 0.04% 145
2023
Q4
$171K Buy
1,043
+870
+503% +$131K 0.05% 146
2023
Q3
$24.3K Buy
+173
New +$24.6K 0.01% 171

Other funds holding IBM

Arlington Trust's IBM Position: Q2 2026 in Review

Arlington Trust reduced its IBM (IBM) stake by 42% in Q2 2026, selling an estimated $7.56K and leaving 42 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

Arlington Trust first reported a position in IBM in Q3 2023 and has held it in 12 quarters since. The position peaked at $428K in Q4 2024. 2,149 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Arlington Trust held 42 shares of IBM worth $11.8K as of Q2 2026.
  • Arlington Trust sold 30 IBM shares in Q2 2026, an estimated $7.56K.
  • IBM made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #449 holding.
  • Arlington Trust first reported a position in IBM in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's IBM position peaked at $428K in Q4 2024.
  • 2,149 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.